Free Trial Free TrialFree Trial

More results...

Filter by Content types
Regulatory data
Regulatory reports
Market reports
News analysis

Alerts LATEST ALERTS

  • South Africa Committee shows mixed reactions to tobacco control bill…
  • Europe EC answers MEP question over possible conflict of interest…
  • Ukraine Resolution published on restricting minors’ access to heated tobacco websi ...
  • Russia State Duma passes bill to license production and distribution…
  • Bulgaria Heated tobacco flavours ban goes to consultation…
  • Spain MEPs call for EU regulation of novel tobacco products…
  • Canada Heated tobacco to be subjected to larger, rotating health warnings…
  • Vietnam National Assembly hears call for total ban on ‘new generation cigarettes’…
  • World WHO calls for ending subsidies for tobacco farming…
  • Europe Commissioner releases statement on World No Tobacco Day…
  • Czech Republic Bill addressing heated tobacco flavour ban is adopted…
  • Ukraine Advertising Act amendment bill adopted…
View all
News analysis

The FDA’s new philosophy: ‘We need to take a fresh look at nicotine’

Written by || 31st July 2017 || News analysis | Combustibles | Politics & policy | Vapour | North America United States

Scott Gottlieb, commissioner of the US FDA, appeared on Friday to go further than any federal official – or most politicians – previously had in supporting alternative nicotine products for harm reduction ...

Benefits of subscription plans:

  • Stay informed of any legal and market change in the sector that impacts your organization
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization

Need help?

Contact a sales representative right now and don’t wait

Email us

Related contents

FDA moves on nicotine levels in combustibles, leaving e-cigs alone
FDA squeeze on nicotine in combustibles could hasten Big Tobacco move to HnB
New views on nicotine: now the FDA is reconsidering NRT, too
© 2023
TobaccoIntelligence does not provide legal, strategic or investment advice. Tamarind Media Limited, the publisher of TobaccoIntelligence,
does not accept any liability or responsibility for information or views published.